Stockscreener 앱 받기
0.7486
1.50%
-0.0114
시간 외 거래:
1.96
1.2114
+161.82%
전일 마감가:
$0.76
열려 있는:
$0.77
하루 거래량:
162.83K
Relative Volume:
0.76
시가총액:
$37.29M
수익:
$2.82M
순이익/손실:
$-13.47M
주가수익비율:
-1.1009
EPS:
-0.68
순현금흐름:
$-13.61M
1주 성능:
-1.24%
1개월 성능:
+1.31%
6개월 성능:
-30.04%
1년 성능:
+1.01%
1일 변동 폭
$0.717
$0.77
1주일 범위
$0.717
$0.8589
52주 변동 폭
$0.3954
$1.39
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
명칭
Neuroone Medical Technologies Corp
전화
(952) 426-1383
주소
7599 ANAGRAM DR, EDEN PRAIRIE
NMTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.70 | 979.09M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.28 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.65 | 111.10M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.168 | 327.43M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.30 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-05 | 개시 | Ladenburg Thalmann | Buy |
| 2022-03-29 | 다운그레이드 | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp 주식(NMTC)의 최신 뉴스
Can NeuroOne Medical Technologies Corporation hit a new high this monthFree High Return Stock Focus With Safety - Newser
Published on: 2025-08-10 05:12:13 - Newser
Published on: 2025-08-09 20:27:53 - Newser
Why NeuroOne Medical Technologies Corporation stock attracts strong analyst attentionFree Sector Rotation Based Trading Opportunities - Newser
Published on: 2025-08-08 23:32:40 - Newser
Exit strategy if you’re trapped in NeuroOne Medical Technologies CorporationWeekly Portfolio Update with ROI Focus - Newser
Does NeuroOne Medical Technologies Corporation show high probability of reboundFree Confirmed Setup With Expert Accuracy - Newser
NeuroOne Medical Technologies Corporation stock retracement – recovery analysisAI Screener for Daily Stock Forecast - Newser
Why NeuroOne Medical Technologies Corporation is moving todayPrice Action Trading with Volume Confirmation - Newser
NeuroOne Medical Technologies Corporation Stock Chart Analysis: Bullish or Bearish Pattern FormingConsistent Gain Plan with AI Support - Newser
Will NeuroOne Medical Technologies Corporation outperform the marketInsider Strategy for High Conviction Picks - Newser
What MACD signals say about NeuroOne Medical Technologies CorporationLow Risk Stock Selection Strategy Guide - Newser
Published on: 2025-08-04 09:36:17 - metal.it
What institutional investors are buying NeuroOne Medical Technologies Corporation stockAchieve breakthrough gains with expert advice - Jammu Links News
What indicators show strength in NeuroOne Medical Technologies CorporationFree Real Market Momentum Signal Generator - Newser
What are the technical indicators suggesting about NeuroOne Medical Technologies CorporationAchieve breakthrough profits with expert advice - Jammu Links News
Why is NeuroOne Medical Technologies Corporation stock attracting strong analyst attentionMarket Forecast Alerts To Watch Now - Jammu Links News
NeuroOne Medical Technologies Corporation Stock Performance After Earnings: Historical InsightsAI Volatility Forecast and Risk Monitor - Newser
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern TimeUpdate - The Globe and Mail
NeuroOne Medical Technologies to Announce Fiscal Q3 2025 Financial Results on August 14, 2025 - Quiver Quantitative
NeuroOne Medical Tech Q3 Earnings Call: Key Updates Coming for Neurological Device Maker - Stock Titan
How to build a dashboard for NeuroOne Medical Technologies Corporation stockFree Low Drawdown Real Time Trading Tips - Newser
What technical models suggest about NeuroOne Medical Technologies Corporation’s comebackHigh Reward Investment Strategy for Beginners - Newser
Published on: 2025-07-29 21:58:21 - metal.it
How did NMTC's Q1 2025 EPS surprise investors? - AInvest
What makes NeuroOne Medical Technologies Corporation stock price move sharplyWeekly Portfolio Update with ROI Focus - Newser
Is NeuroOne Medical Technologies Corporation forming a bottoming baseAlpha Generation Strategy with Low Volatility - Newser
What are NeuroOne Medical Technologies Corporation company’s key revenue driversPre Market Entry Points That Work - Jammu Links News
What indicators show strength in NeuroOne Medical Technologies Corporation Investment Life Cycle Planning Summary - Newser
What is the dividend policy of NeuroOne Medical Technologies Corporation stockGet timely alerts on market movers - Jammu Links News
How volatile is NeuroOne Medical Technologies Corporation stock compared to the marketInvest confidently with daily market forecasts - Jammu Links News
Does NeuroOne Medical Technologies Corporation stock perform well during market downturnsTrack high-yield stocks before they peak - Jammu Links News
Critical Contrast: So-Young International (NASDAQ:SY) vs. NeuroOne Medical Technologies (NASDAQ:NMTC) - Defense World
Company News for Jul 24, 2025 - The Globe and Mail
What drives NeuroOne Medical Technologies Corporation stock priceOverwhelming financial success - Autocar Professional
NeuroOne receives USPTO patent allowance for neural probe technology By Investing.com - Investing.com Nigeria
NeuroOne Medical Technologies Secures Notice of Allowance for Key Neural Probe Patent - Quiver Quantitative
NeuroOne receives USPTO patent allowance for neural probe technology - Investing.com
NeuroOne Strengthens Neural Tech Leadership with Strategic USPTO Patent for Advanced Electrode Technology - Stock Titan
What analysts say about NeuroOne Medical Technologies Corporation stockOverwhelming profit margins - Autocar Professional
Is NeuroOne Medical Technologies Corporation a good long term investmentBreakout profit opportunities - jammulinksnews.com
NeuroOne Medical Technologies Corporation Stock Analysis and ForecastAccelerated investment success - jammulinksnews.com
81,000 Shares in NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Bought by Cambridge Investment Research Advisors Inc. - Defense World
Neuroone Medical Technologies Corp (NMTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):